Verified peptide sources, COAs, vendors, labs, batches, and prices.
What's actually on file: 5,769 independent COAs linked to peptide, lab, batch, and date. We catalog the evidence. You decide.
The FDA is deciding this week whether these compounds return to compounding.
The FDA's Pharmacy Compounding Advisory Committee (PCAC) is scheduled to meet July 23–24, 2026 to weigh returning BPC-157, TB-500, MOTS-c, KPV, and Semax to the 503A bulk substances list. If approved, some demand would shift to licensed compounding pharmacies — a meaningful change for vendors currently operating in the gray market. The meeting is driven in part by MAHA-era regulatory easing pressure.
We don't predict the outcome — we track the docket and the independent evidence on file today, whichever way it goes. Not legal or medical advice.
BPC-157
from $1.10/mg
Evidence on file →Cat. 2 reviewPentadecapeptide BPC (Oral)
18 sellers
Evidence on file →Cat. 2 reviewTB-500
from $2.92/mg
Evidence on file →Cat. 2 reviewMOTS-c
from $0.60/mg
Evidence on file →Cat. 2 reviewKPV
from $0.56/mg
Evidence on file →Cat. 2 reviewSemax
from $1.00/mg
Evidence on file →What are you researching?
Jump straight to live prices, checked sellers, and the COA evidence for the compound you came for.
Healing & Recovery
BPC-157
from $1.10/mg· 90 sellers
Compare sellers →GLP-1 / Metabolic
Tirzepatide
from $0.50/mg· 74 sellers
Compare sellers →GLP-1 / Metabolic
Retatrutide
from $0.67/mg· 81 sellers
Compare sellers →GLP-1 / Metabolic
Semaglutide
from $0.50/mg· 62 sellers
Compare sellers →Healing & Recovery
TB-500
from $2.92/mg· 84 sellers
Compare sellers →Growth Hormone Secretagogues
Ipamorelin
from $2.70/mg· 83 sellers
Compare sellers →Growth Hormone Secretagogues
CJC-1295
from $2.84/mg· 72 sellers
Compare sellers →Healing & Recovery
GHK-Cu
from $0.09/mg· 94 sellers
Compare sellers →Codes that work at checked vendors
Every code below is confirmed working at a vendor with independent COA evidence on file. Ordered by Merit Score — never by commission.
Pick where to start
Each peptide class has its own evidence pattern — which labs cover it, how recent the COAs are, where the data runs thin.
GLP-1 / Metabolic
GLP-1 receptor agonists and related metabolic / weight-management peptides.
Growth Hormone Secretagogues
GHRH analogues and GHS-R agonists (CJC-1295, Ipamorelin, MK-677, etc.).
Healing & Recovery
Peptides studied for tissue repair, wound healing, and recovery from injury.
Immune Modulator
Thymic and immune-modulating peptides.
Melanocortin
Melanocortin receptor agonists (Melanotan II, PT-141, etc.).
Nootropic / Cognitive
Peptides studied for neuroprotection, cognition, and CNS effects.
Recently verified COAs
25 independent COAs added in the last 7 days, 273 in the last 30, across 17 active labs — counted and refreshed daily, not a frozen snapshot.
The peptide aisle, decoded.
Every vendor's independent COAs on file. Every peptide linked to its lab evidence. Updated as new tests land. No paid placement.
Trusted labs
The third-party labs producing COAs in the directory. Ranked by COA volume on file.
Most COAs on file
Vendors ranked by independent COA count. Open a profile to browse the actual tests — lab, batch, purity, date.
What the literature says
Citations indexed by peptide and study type. Mechanism, dose-response, where the evidence is strong and where it gets thin.
rct · 2027 · on Testagen
Product Transference Study of Testagen™ TDS®-Testosterone
This study will assess the potential of Testagen® TDS-Testosterone to enable transfer of Testosterone to females coming in contact with skin to which Testagen® TDS-Testosterone has been applied and the potential of product to raise serum androgen levels in those women.
Open source →cohort · 2027 · on MOTS-c
Mitophagy and Mitochondrial DNA Dynamics During Ramadan Dry Fasting vs 16:8 Time-Restricted Feeding
This study investigates how different types of fasting affect cell health, specifically focusing on how mitochondria (the energy-producing parts of cells) are cleared and renewed.
Open source →rct · 2027 · on GHK-Cu
Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults
The goal of this clinical trial is to investigate GHK and GHK-Cu blood levels pre- and post-intervention in healthy adults, and to investigate the efficacy of X39 patch on GHK and GHK-Cu blood levels in healthy adults compared to a placebo.
Open source →Pick a peptide, see the evidence on file, and decide if the vendor is worth your money.
Independent. No paid placement. Updated as new evidence and new COAs land.